(Q42693130)

English

No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus

scientific article published on 22 December 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

No resistance to tenofovir disoproxil fumarate detected after up to 144 weeks of therapy in patients monoinfected with chronic hepatitis B virus (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

Patrick Marcellin

12

object named as

Patrick Marcellin

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

author name string

Andrea Snow-Lampart

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Brandi Chappell

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Maria Curtis

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Yuao Zhu

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Florence Myrick

5

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

James Schawalder

6

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Kathryn Kitrinos

7

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Evguenia S Svarovskaia

8

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Michael D Miller

9

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Jeff Sorbel

10

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Jenny Heathcote

11

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Katyna Borroto-Esoda

13

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

language of work or name

0 references

publication date

22 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

763-773

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Four years of lamivudine treatment in Chinese patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24078

21 January 2018

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24078

21 January 2018

2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24078

21 January 2018

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24078

21 January 2018

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24078

21 January 2018

Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24078

21 January 2018

Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24078

21 January 2018

MultiCode-RTx real-time PCR system for detection of subpopulations of K65R human immunodeficiency virus type 1 reverse transcriptase mutant viruses in clinical samples

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24078

21 January 2018

Quantifying mixed populations of drug-resistant human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24078

21 January 2018

Chronic hepatitis B: update 2009

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24078

21 January 2018

The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24078

21 January 2018

YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24078

21 January 2018

In vitro activity of 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]-pyrimidine against multidrug-resistant hepatitis B virus mutants

1 reference

https://api.crossref.org/works/10.1002%2FHEP.24078

21 January 2018

Identifiers

10.1002/HEP.24078

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42693130&oldid=1965633461"